1200 related articles for article (PubMed ID: 19301378)
61. [Polyneuropathy associated with monoclonal gammapathy: treatment perspectives].
Leger JM; Chassande B; Bombelli F; Viala K; Musset L; Neil J
Bull Acad Natl Med; 2009 May; 193(5):1099-110; discussion 1110-1. PubMed ID: 20120390
[TBL] [Abstract][Full Text] [Related]
62. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
[TBL] [Abstract][Full Text] [Related]
63. Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
Dyck PJ; Taylor BV; Davies JL; Mauermann ML; Litchy WJ; Klein CJ; Dyck PJ
Muscle Nerve; 2015 Oct; 52(4):488-97. PubMed ID: 25976871
[TBL] [Abstract][Full Text] [Related]
64. Pathology of inflammatory demyelinating neuropathies.
Prineas JW
Baillieres Clin Neurol; 1994 Apr; 3(1):1-24. PubMed ID: 7921584
[TBL] [Abstract][Full Text] [Related]
65. Predicting treatment response in chronic, acquired demyelinating neuropathies.
Chan YC; Wilder-Smith E
Expert Rev Neurother; 2006 Oct; 6(10):1545-53. PubMed ID: 17078793
[TBL] [Abstract][Full Text] [Related]
66. The treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Kissel JT
Semin Neurol; 2003 Jun; 23(2):169-80. PubMed ID: 12894382
[TBL] [Abstract][Full Text] [Related]
67. Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan.
Nobile-Orazio E; Gallia F; Terenghi F; Bianco M
Expert Rev Neurother; 2017 Aug; 17(8):755-765. PubMed ID: 28597710
[TBL] [Abstract][Full Text] [Related]
68. Treatment of dys-immune neuropathies.
Nobile-Orazio E
J Neurol; 2005 Apr; 252(4):385-95. PubMed ID: 15834625
[TBL] [Abstract][Full Text] [Related]
69. Challenges in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Guimarães-Costa R; Iancu Ferfoglia R; Viala K; Léger JM
Rev Neurol (Paris); 2014 Oct; 170(10):595-601. PubMed ID: 25200479
[TBL] [Abstract][Full Text] [Related]
70. Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment.
Pedersen K; Pandolfo M; Mavroudakis N
Acta Neurol Belg; 2007 Mar; 107(1):14-7. PubMed ID: 17569228
[TBL] [Abstract][Full Text] [Related]
71. [Recent advances of immune therapies for demyelinating neuropathies].
Ito H; Saito T
Rinsho Shinkeigaku; 1997 Dec; 37(12):1111-2. PubMed ID: 9577661
[TBL] [Abstract][Full Text] [Related]
72. [Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
Kuntzer T
Rev Neurol (Paris); 2006 Apr; 162(4):539-43. PubMed ID: 16585918
[TBL] [Abstract][Full Text] [Related]
73. The role of IVIg in autoimmune neuropathies: the latest evidence.
Hughes R
J Neurol; 2008 Jul; 255 Suppl 3():7-11. PubMed ID: 18685920
[TBL] [Abstract][Full Text] [Related]
74. Acquired inflammatory demyelinating neuropathies.
Ensrud ER; Krivickas LS
Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
[TBL] [Abstract][Full Text] [Related]
75. Plasma exchange in immune-mediated neuropathies.
Lehmann HC; Hartung HP; Meyer Zu Hörste G; Kieseier BC
Curr Opin Neurol; 2008 Oct; 21(5):547-54. PubMed ID: 18769248
[TBL] [Abstract][Full Text] [Related]
76. Multifocal motor neuropathy.
Van Asseldonk JT; Franssen H; Van den Berg-Vos RM; Wokke JH; Van den Berg LH
Lancet Neurol; 2005 May; 4(5):309-19. PubMed ID: 15847844
[TBL] [Abstract][Full Text] [Related]
77. Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathies.
Gallia F; Balducci C; Nobile-Orazio E
J Peripher Nerv Syst; 2016 Jun; 21(2):82-4. PubMed ID: 26817673
[TBL] [Abstract][Full Text] [Related]
78. IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy.
Lombardi R; Erne B; Lauria G; Pareyson D; Borgna M; Morbin M; Arnold A; Czaplinski A; Fuhr P; Schaeren-Wiemers N; Steck AJ
Ann Neurol; 2005 Feb; 57(2):180-7. PubMed ID: 15668968
[TBL] [Abstract][Full Text] [Related]
79. Testing for anti-glycolipid IgM antibodies in chronic immune-mediated demyelinating neuropathies.
Nobile-Orazio E; Giannotta C
J Peripher Nerv Syst; 2011 Jun; 16 Suppl 1():18-23. PubMed ID: 21696492
[TBL] [Abstract][Full Text] [Related]
80. [Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives].
Léger JM; Chassande B
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S19-23. PubMed ID: 10896984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
